Photo: STAT News

ICMR Study Reveals 3 Out Of 5 Monkeypox Cases In Delhi Had Heterosexual Contact

According to a preliminary investigation conducted by the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV), three of the five Monkeypox cases reported from Delhi had a history of heterosexual interaction. However, the other two cases out of five have no sexual interaction. All five individuals had mild to moderate grade intermittent fever, myalgia, and genital, groin, lower limb, trunk, and upper limb symptoms.… read-more

Fri, 26 Aug 2022 - 11:45 AM / by Vidhi Jhunjhunwala

Tags: Monkeypox, Delhi, Homosexual, ICMR, national institute of virology

Courtesy: DNA INDIA


Photo: Medical Xpress

‘Monkeypox Does Not Lead To HIV,’ Says Top ICMR Scientist

The global monkeypox epidemic has alarmed senior medical authorities. Because of the taboos surrounding monkeypox, many have linked it to the spread of HIV in India. Dr. Pragya Yadav, a prominent scientist at the Indian Council of Medical Research-National Institute of Virology, clarified the growing myths… read-more

Tue, 23 Aug 2022 - 12:55 PM / by Vidhi Jhunjhunwala

Tags: Monkeypox, HIV Spread, ICMR, Scientist, ICMR-NIV

Courtesy: DNA INDIA

ICMR DG Dr Balram Bhargava

Photo: The Times Of India

ICMR Director General's Tenure Extended By 3 Months

The ICMR Director-General Dr. Balram Bhargava's term has been extended for another three months. In April, the appointment committee of the cabinet approved the extension, following which Bhargava will continue as the secretary of health research and director-general of the ICMR. Starting from April 15, Dr Bhargava's term would end on July 15. Notably, Dr. Balram Bhargava was appointed as the ICMR Director-General on April 16, 2018.

Tue, 12 Apr 2022 - 01:16 PM / by Varsha Joshi

Tags: ICMR, Dr Balram Bhargava, Tenure Extended, Cabinet, Delhi

Courtesy: ANI


Photo: The Scientist Magazine

India To Get TB Vaccine By 2024, Says ICMR

The Indian Council of Medical Research (ICMR) and the National AIDS Research Institute (NARI) are working together for a vaccine for the vaccine of Tuberculosis (TB).  As per ANI, the trials for the vaccine are under phase-3, in 18 subsites of India.  A total of 1,593 participants were selected randomly, with a follow-up of 38 months. If successful, India will get two effective vaccines, VPM002 and Immuvac (TB) by 2024. 

Fri, 01 Apr 2022 - 10:30 AM / by Varsha Joshi

Tags: Tuberculosis, ICMR, NARI, 2024, Indian Vaccine

Courtesy: ANI

Director Controller General of India

Photo: The Statesman

DCGI Approves India Made RT-PCR Kit To Detect Omicron

The Director Controller General of India (DCGI) approved India made RT-PCR kit to detect new COVID-19 variant "Omicron".  On January 5, ICMR General Director Dr Balram Bhagava said, the new RT-PCR kit has been manufactured by Tata MD and ICMR, to test Omicron. "This kit test will give results in four hours," said Dr. Bhagava. Meanwhile, in India, there are a total of 2,135 Omicron cases. 

Wed, 05 Jan 2022 - 06:51 PM / by Varsha Joshi

Tags: omicron, DCGI, ICMR, Dr Balram Bhargav, RT-PCR Kit

Courtesy: ANI


Photo: Indian Express

No Scientific Evidence For Need Of COVID-19 Booster Dose; ICMR

Dr. Samiran Panda, head of Epidemiology and infectious diseases at the Indian Council of Medical Research (ICMR) said that there is no scientific evidence for the need for a COVID-19 booster dose in the country. According to his statement, policy formulation and decisions are based on scientific evidence. "There has been no evidence for the need for COVID boosters. As of now, attaining full vaccination is the first priority", Panda added.

Sun, 21 Nov 2021 - 07:04 PM / by SAM RAHUL RAJASHEKHAR

Tags: covid 19, Booster shot, Coronavirus, India, ICMR

Courtesy: ANI

ICMR to priortise children above 12 years of age for vaccination

Photo: The Times of India

ICMR To Prioritize Children Above 12 For Vaccination

According to research reports, children aged 12 and above are at a higher risk of contracting coronavirus. The fourth round of the National Serosurvey in June 2021 concluded that children between the age group of 6 to 17 were seropositive and mostly had caught the virus. ICMR has suggested the medical practitioners and the government to prioritize children's above 12 for the vaccines first.

Tue, 28 Sep 2021 - 05:05 PM / by Muskan Arora

Tags: Covid-19, ICMR, ICMR Research, National Serosurvey, Coronavirus Vaccines

Courtesy: The Hindu

Covid deaths in India

Photo: Al Jazeera

Centre Issues Guidelines To Estimate Covid Deaths In India

Owing to Supreme Court's order, the central government and the Indian Council of Medical Research (ICMR) have jointly issued Covid related death guidelines for issuing 'official documents'. Guidelines outline- those diagnosed positive through RT-PCR/Antigen test, or an in-patient facility by a physician, are to be considered as Covid death. Also, deaths within 30 days, however, ICMR advised within 25 days, are to be treated as Covid deaths.… read-more

Sun, 12 Sep 2021 - 08:41 PM / by Ettishree Shukla

Tags: Covid-19, Central Government, Supreme Court, ICMR

Courtesy: The Indian Express

Two vials of drugs

Photo: The Times of India

Mixing Of Different Vaccines Produce Good Results: ICMR Research

ICMR has revealed that the mixing of two different vaccines based on the ''adenovirus vector'' does not produce any adverse effects. Furthermore, the research revealed that mixing helps to fight the COVID-19 virus and also produces immunity better than excepted. The research in India also helps to mitigate the rumors about the adverse effects of vaccines. Reportedly, many countries have proven this process to be promising.

Sun, 08 Aug 2021 - 08:43 PM / by Brijesh Goswami

Tags: ICMR, Coronavirus Vaccines, Mixed Dose, COVISHIELD, Covaxin

Courtesy: News Daily India

Covaxin developed by Bharat Biotech


India's Covaxin Effective Against Delta+ Variant, Claims ICMR Study

According to the study done by the Indian Council of Medical Research (ICMR), India's Covaxin developed by Bharat  Biotech is potent against the Delta Plus (AY.1) variant of the SARS-CoV2 virus. The Delta AY.1 variant was first detected in India in April 2021 but is found to be low. "Our research showed that Covaxin could still neutralize Delta, AY.1 and B.1.617.3 variants," said Dr. Samiran Panda, head of epidemiology and communicable… read-more

Tue, 03 Aug 2021 - 05:03 PM / by Prateek Chakradhar

Tags: Covid-19, Covaxin, ICMR, Delta Variant

Courtesy: Indian Express